Piramal Enterprises’ Consumer Products Division has entered into an agreement to acquire four brands from Pfizer for a consideration of Rs 110 crore. The acquisition includes brands namely; Ferradol, Neko, Sloan’s and Waterbury’s Compound.
Additionally, the agreement also includes the trademark rights for Ferradol and Waterbury’s Compound in Bangladesh and Sri Lanka. These brands hold a rich legacy and have a high consumer pull and are available in India for the past 30 plus years. These products currently operate in a market which is currently estimated at Rs 7000 crore. Completion of the deal is subject to certain conditions including regulatory approvals.
Piramal Enterprises is one of the leading players globally in CRAMS (custom research and manufacturing services) as well as in the critical care segment of inhalation and injectable anaesthetics. It also has a strong presence in the OTC segment in India.
